| Dr Edward Jermaine Anderson, MD, PT | |
|
33600 W 85th St, De Soto, KS 66018-8118 | |
| (913) 583-1260 | |
| Not Available |
| Full Name | Dr Edward Jermaine Anderson |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 33600 W 85th St, De Soto, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942592498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 11-03428 (Kansas) | Primary |
| Provider Name | Encore Rehabilitation Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336896240 PECOS PAC ID: 8123403904 Enrollment ID: O20220921000955 |
News Archive
Being underweight puts people at highest risk of dying, just as obesity does, new research has found. The connection between being underweight and the higher risk of dying is true for both adults and fetuses.
Amedisys Inc., one of America's leading home health nursing companies, today announced that it has signed a national agreement with Humana Inc. to provide home health services to Humana's Medicare Advantage members effective Jan. 1, 2010.
Vertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.
Colonoscopy is one of the most effective cancer screening procedures available. Colon cancer grows very slowly and can be treated if caught early through screening. But, perhaps because of this success, older Americans are undergoing screening colonoscopies despite recommendations against screening in adults aged 76 and older.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward Jermaine Anderson, MD, PT 8650 Winchester St, 2202, Lenexa, KS 66219-8109 Ph: (913) 709-5732 | Dr Edward Jermaine Anderson, MD, PT 33600 W 85th St, De Soto, KS 66018-8118 Ph: (913) 583-1260 |
News Archive
Being underweight puts people at highest risk of dying, just as obesity does, new research has found. The connection between being underweight and the higher risk of dying is true for both adults and fetuses.
Amedisys Inc., one of America's leading home health nursing companies, today announced that it has signed a national agreement with Humana Inc. to provide home health services to Humana's Medicare Advantage members effective Jan. 1, 2010.
Vertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.
Colonoscopy is one of the most effective cancer screening procedures available. Colon cancer grows very slowly and can be treated if caught early through screening. But, perhaps because of this success, older Americans are undergoing screening colonoscopies despite recommendations against screening in adults aged 76 and older.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 3 days ago